1.
Veelken K, Schönland S, Dittrich T, Kimmich C, Granzow M, Jauch A, Müller-Tidow C, Raab MS, Hegenbart U. Retrospective cohort study of treatment with BCL-2 inhibitor venetoclax in advanced AL amyloidosis. Haematologica; https://doi.org/10.3324/haematol.2025.288635 [Early view].